Related Experiment Video
Updated: Jun 12, 2026

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
Translating clinical research to the bedside: the Minnesota model
Jennifer L Hall1, Leslie W Miller, Soon J Park
1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA.
Abstract:
Minnesota is home to two of the pioneering institutions that ushered in the golden era of modern cardiac surgery. Clinicians and researchers at the Mayo Clinic and the University of Minnesota built on this momentum and began translating clinical research directly to the bedside. This legacy continues today. Minnesota has a rich history and track record of translating clinical research to the bedside and developing medical device companies that have benefited investigators, patients, and the economy. We will give a brief overview of this model and the steps to success which can be duplicated by other states and countries.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
The Scientific Method in Nursing Process
When using research findings to change practice, one must understand the process used to guide a study. The scientific method is a systematic, step-by-step process that supports the data's validity, reliability, and generalizability. As a result, findings can be safely...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions